Navigation Links
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Date:5/9/2008

A>. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com

Keryx Biopharmaceuticals, Inc.

Selected Consolidated Financial Data

(Thousands of Dollars, Except Share and Per Share Data)

Statements of Operations Information:

Three Months Ended March 31,

(unaudited)

2008 2007

REVENUE:

License revenue $199 $ --

Diagnostic revenue -- 30

Service revenue -- 12

TOTAL REVENUE 199 42

OPERATING EXPENSES:

Cost of diagnostics sold -- 22

Cost of services -- 32

Research and development:

Non-cash compensation (980) 995

Other research and development 30,828 17,446

Total research and development 29,848 18,441

Selling, general and administrative:

Non-cash compensation 1,717 2,006

Other selling, general and administrative 1,967 2,795

Total selling, general and administrative 3,684 4,801

TOTAL OPERATING EXPENSES 33,532 23,296

OPERATING LOSS
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
(Date:12/22/2014)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP), ... development of autologous cell therapies, announced today the publication ... in conjunction with co-authors from Kyoto University and the ... ongoing clinical research using dermal sheath cup (DSC) cells ... The paper entitled " Hair Follicle Dermal Stem Cells ...
(Date:12/22/2014)... The American Journal of Hematology/Oncology, ... and editorials addressing developments and pathways related to ... provocative article exploring the role of follicle-stimulating hormone ... of prostate cancer. , The article references ... that there could be a connection to prostate ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... Calif. , May 21 InterMune, Inc. (Nasdaq: ITMN ) ... Senior Vice President, Clinical Affairs of InterMune, will present at the 2010 Citi ... at 3 p.m. EDT . , ... To access a live audio webcast of the presentation, investors and other interested ...
... SEATTLE and CHICAGO , May 20 Dendreon Corporation ... analyses of three Phase 3 PROVENGE® (sipuleucel-T) clinical trials of an autologous cellular ... the American Society of Clinical Oncology (ASCO) in Chicago on ... , , ...
... TRIANGLE PARK, N.C. , May 20 Talecris Biotherapeutics Holdings Corp. ... and chief executive officer of Talecris, will present at the 2010 Citi Investment ... 27, 2010 , at the Hilton New York Hotel in New York, ... A live webcast of ...
Cached Biology Technology:InterMune to Present at 2010 Citi Health Care Conference 2Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 4Dendreon Announces Presentation of PROVENGE Data at the American Society of Clinical Oncology Annual Meeting 5Talecris Biotherapeutics to Present at the 2010 Citi Investment Research Global Health Care Conference 2
(Date:12/22/2014)... Dec. 22, 2014  The 2014 Holiday Season ... industry as Acuity Market Intelligence reports that the ... be open. Acuity forecasts that intensifying demand for ... incorporate biometrics will drive a global market of ... devices by 2020.   According to ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
(Date:12/17/2014)... Dec. 16, 2014  Automation is fundamentally transforming ... evident than at international borders. Over the past ... have allowed veteran travelers to self process through ... (APC) Kiosks at an increasing number of airports, ... According to Maxine Most , ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... (May 20, 2010) -- The nervous system is the ... synapses, and signals that control much of our physiology and ... of the nervous system in the laboratory, scientists have turned ... displays many of the complexities of our own nervous system. ...
... Medical Institute (HHMI) today announced new grants totaling $79 ... science education nationwide. The resources will let faculty at ... by developing new ways to teach and inspire students ... the awards through its Precollege and Undergraduate Science Education ...
... spill threatening fragile coastal wetlands, clean-up crews are about to ... will help limit the environmental damage. That,s the topic of ... newsmagazine. C&EN Assistant Editor Michael Torrice notes that ... to clean up the spill, in which millions of gallons ...
Cached Biology News:New lab manual for studying the biology of the nervous system in Drosophila is released 2HHMI awards $79 million for science education to research universities, top scientists 2HHMI awards $79 million for science education to research universities, top scientists 3HHMI awards $79 million for science education to research universities, top scientists 4HHMI awards $79 million for science education to research universities, top scientists 5
PC based system for advanced chemifluorescent, chemiluminescent, fluorescent and colorimetric, microarray and microscope imaging and analysis....
Pendrin (H-195)...
... A thermostable, thermoactive designer enzyme that ... AccuRT RNA PCR enzyme allows reverse ... performed at elevated temperatures (65C), which ... the template and results in highly ...
HLA-DRbeta (DA2)...
Biology Products: